D-1582-2014 Class II Terminated

Recalled by Apotex Inc. — Toronto

FDA drug recall D-1582-2014 was initiated by Apotex Inc. on Mar 24, 2014 and is designated Class II. Reason for recall: Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents. The recall status is terminated (terminated Sep 23, 2014).

Recall details

Product Type
Drugs
Report Date
Sep 10, 2014
Initiation Date
Mar 24, 2014
Termination Date
Sep 23, 2014
Voluntary/Mandated
Voluntary: Firm initiated

Product description

PAXIL (Paroxetine HCL) Tablets 40 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3666-3

Reason for recall

Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot # 2ZP3908, Exp. 05/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1582-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1582-2014. Report a data issue: hello@regdatalab.com.